RSS-Feed abonnieren
DOI: 10.1055/s-0038-1647449
D-Dimers, Thrombin Antithrombin III Complexes and Prothrombin Fragments 1 + 2: Diagnostic value in Clinically Suspected Deep Vein Thrombosis
Publikationsverlauf
Received 14. Juni 1990
Accepted after revision 21. August 1990
Publikationsdatum:
02. Juli 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199101/lookinside/thumbnails/10-1055-s-0038-1647449-1.jpg)
Summary
This study was performed to determine the accuracy of D-Dimer fibrin derivatives, thrombin-antithrombin III (TAT) complexes and prothrombin fragments 1 + 2 (F 1 + 2) determinations for the diagnosis of deep vein thrombosis (DVT). One hundred and sixteen consecutive patients referred to the angiology unit of our hospital for a clinically suspected DVT were investigated. They were submitted to mercury strain gauge plethysmography and to ultrasonic duplex scanning examination; in cases of inconclusive results or of proximal DVT (n = 35), an ascending phlebography was performed. After these investigations were completed, the diagnosis of DVT was confirmed in 34 and excluded in 82. One half of the patients were already under anticoagulant therapy at the time of investigation. The 3 biological markers were assayed using commercially available ELISA techniques and the D-Dimer was also assayed with a fast latex method. The normal distribution of these markers was established in 40 healthy blood donors. The most accurate assay for the diagnosis of DVT was the D-Dimer ELISA which had both a high sensitivity (94%) and a high negative predictive value (95%). The D-Dirner latex, TAT complexes and F 1 + 2 were far less sensitive and provided negative predictive values which ranged between 78 and 85%. In spite of positive and significant correlations between the levels of ihe 3 markers, their association did not improve their overall accuracy for detecting D\/L Therefore, with the exception of the D-Dimer ELISA, these markers were of little value for the diagnosis of DVT in this specific population.
-
References
- 1 Hirsh H, Hull R. In: Venous Thromboembolism: Natural History, Diagnosis and Management CRC Press; Boca Raton, FL: 1987: 23-48
- 2 Wojciechowski J, Olausson M, Korsan-Bengien K. Fibrinopeptide A, beta-thromboglobulin, and fibrin degradation products as screening test for the diagnosis of deep vein thrombosis. Haemostasis 1983; 13: 254-261
- 3 Whitaker A, Elms M, Masci P, Bundesen P, Rylatt D, Webber A, Bunce I. Measurement of crosslinked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies. J Clin Pathol 1984; 37: 882-887
- 4 Heaton D, Billings J, Hickton C. Assessment of D-Dimer assays for the diagnosis of deep vein thrombosis. J Lab Clin Med 1987; 110: 588-591
- 5 Roul C, Elias A, Aillaud MF, Villain P, Bouvier J, Serradimigni A, Juhan-Vague I. Evaluation of plasma D-Dimer with 2 methods: latex and Elisa (Diagnostica Stago) in the diagnosis of deep venous thrombosis (DVT). Xth International Congress on Thrombosis; Athens: 06/1988. abstract book 143
- 6 Rowbotham BJ, Carroll P, Whitaker A, Bunce I, Cobcroft R, Elms MJ, Masci P, Bundesen P, Rylatt D, Webber A. Measurement of crosslinked fibrin derivatives. Use in the diagnosis of venous thrombosis. Thromb Haemostas 1987; 57: 59-61
- 7 Ott P, Astrup L, Hartuig JensenR, Nyeland B, Pedersen B. Assessment of D-Dimer in plasma: diagnostic value in suspected deep venous thrombosis of the leg. Acta Med Scand 1988; 224: 263-267
- 8 Bounameaux H, Schneider PA, Reber G, De Moerloose P, Krahen-buhl B. Measurement of plasma D-Dimer for diagnosis of deep venous thrombosis. Am J Clin Pathol 1989; 91: 82-85
- 9 Van Bergen P, Knot E, Jonker J, De Boer A, De Maat M. Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in out patients?. Thromb Haemostas 1989; 62: 1043-1045
- 10 Bauer K, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Review article. Blood 1987; 70: 343-349
- 11 Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemostas 1988; 59: 101-106
- 12 Pelzer H, Stuber W, Dati F, Heimburger N. New trends in the field of coagulation diagnosis - New possibilities to improve monitoring of antithrombotic therapy. Folia Haematol 1989; 116: 867-871
- 13 Mausner JS, Bahn AK. Epidemiology, An Introductory Text. W. B. Saunders Company; Philadelphia, PA: 1974: 237-263
- 14 Boccalon H, Chikhany G, Lozes A, Vaulic C, Puel P, Enjalbert A. Venous plethsmography applied in pathological conditions. Angiology 1981; 32: 822-831
- 15 Elias A, Legorff G, Bouvier JL, Benichou M, Serradimigni A. Value of real time B mode ultrasound imaging in the diagnosis of deep vein thrombosis of the lower limit. Int Angiol 1987; 6: 175-182
- 16 Comerota AJ, Katz ML, Grossi RJ. The comparative value of non-invasive testing for diagnosis and surveillance of deep vein thrombosis. J Vase Surg 1988; 7: 40-49
- 17 Lensing A, Prandoni P, Brandjes D, Huisman PM, Vigo M, Tomasella G, Krekt J, Late JW, Huisman MV, Büller HR. Detection of deep vein thrombosis by real time B mode ultrasonography. N Engl J Med 1989; 320: 342-345
- 18 Stallworth JM, Plong GW, Horne JB. Negative phleborheography clinical follow-up in 593 patients. Ann Surg 1981; 116: 795-797
- 19 Hull RD, Hirsh J, Sackett DL, Stoddart G. Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep vein thrombosis. N Engl J Med 1981; 304: 1561-1567
- 20 Canova B, Lensing AW A, Prandoni P, Büller HR, Cogo A, Ten Cate JW, De Toni R. Thrombin-antithrombin III (T-TAT) complexes in the diagnosis of deep vein thrombosis. Thromb Haemostas 1989; 62: 185 (abst)
- 21 Hoek JA, Sturk A, Ten Cate JW, Lamping RJ, Berends F, Borm JJ. Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma. Clin Chem 1988; 34: 2058-2062